Lotte Fine Chemical Co Ltd
KRX:004000
Lotte Fine Chemical Co Ltd
KRX:004000
Price:
39 150
KRW
-1.76%
Market Closed
Market Cap:
997.2B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Lotte Fine Chemical Co Ltd
39150
-700 (-1.76%)
| 52 Week Range |
33 900
56 600
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Lotte Fine Chemical Co Ltd
Balance Sheet
Balance Sheet Decomposition
Lotte Fine Chemical Co Ltd
Lotte Fine Chemical Co Ltd
| Current Assets | 1T |
| Cash & Short-Term Investments | 488.3B |
| Receivables | 255.4B |
| Other Current Assets | 301B |
| Non-Current Assets | 1.7T |
| Long-Term Investments | 394.9B |
| PP&E | 1T |
| Intangibles | 23.2B |
| Other Non-Current Assets | 273.8B |
| Current Liabilities | 222.1B |
| Accounts Payable | 79.9B |
| Accrued Liabilities | 56.9B |
| Short-Term Debt | 792.2m |
| Other Current Liabilities | 84.5B |
| Non-Current Liabilities | 170.2B |
| Long-Term Debt | 159.1B |
| Other Non-Current Liabilities | 11.1B |
Balance Sheet
Lotte Fine Chemical Co Ltd
Lotte Fine Chemical Co Ltd
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
97 141
|
219 296
|
210 110
|
131 712
|
6 827
|
10 561
|
9 072
|
228 813
|
577 991
|
460 888
|
|
| Cash |
0
|
18
|
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
97 141
|
219 278
|
210 094
|
131 712
|
6 827
|
10 561
|
9 072
|
228 813
|
577 991
|
460 888
|
|
| Short-Term Investments |
28
|
1 031
|
30 109
|
225 089
|
310 762
|
448 036
|
143 276
|
72 137
|
141 368
|
667
|
|
| Total Receivables |
196 433
|
195 783
|
183 447
|
192 772
|
220 064
|
214 208
|
194 700
|
308 881
|
294 595
|
551 240
|
|
| Accounts Receivables |
181 868
|
172 212
|
162 966
|
187 261
|
215 682
|
210 586
|
187 429
|
306 124
|
293 760
|
249 051
|
|
| Other Receivables |
14 565
|
23 571
|
20 481
|
5 511
|
4 382
|
3 622
|
7 271
|
2 757
|
835
|
302 189
|
|
| Inventory |
159 179
|
151 998
|
136 811
|
138 647
|
172 033
|
177 815
|
152 453
|
244 501
|
286 273
|
305 891
|
|
| Other Current Assets |
19 141
|
15 290
|
8 706
|
8 809
|
6 673
|
9 909
|
17 302
|
12 532
|
16 072
|
27 872
|
|
| Total Current Assets |
471 922
|
583 397
|
569 185
|
697 028
|
716 359
|
860 530
|
516 803
|
866 863
|
1 316 299
|
1 346 558
|
|
| PP&E Net |
927 366
|
760 862
|
717 133
|
708 100
|
701 983
|
678 889
|
776 519
|
788 249
|
821 178
|
807 288
|
|
| PP&E Gross |
927 366
|
760 862
|
717 133
|
708 100
|
701 983
|
678 889
|
776 519
|
788 249
|
821 178
|
807 288
|
|
| Accumulated Depreciation |
781 681
|
825 925
|
869 170
|
898 216
|
967 167
|
1 047 669
|
1 092 767
|
1 174 634
|
1 237 875
|
1 313 631
|
|
| Intangible Assets |
34 165
|
30 141
|
20 671
|
15 097
|
25 818
|
24 104
|
22 887
|
20 382
|
22 605
|
20 519
|
|
| Goodwill |
3 556
|
3 459
|
3 459
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
3 486
|
18 293
|
1 329
|
2 389
|
0
|
78
|
0
|
0
|
0
|
17
|
|
| Long-Term Investments |
277 438
|
282 136
|
194 953
|
215 266
|
254 013
|
227 232
|
554 327
|
1 038 245
|
485 135
|
435 606
|
|
| Other Long-Term Assets |
128 028
|
5 938
|
24 209
|
3 424
|
1 856
|
1 851
|
4 053
|
9 715
|
64 627
|
72 943
|
|
| Other Assets |
3 556
|
3 459
|
3 459
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1 845 960
N/A
|
1 684 225
-9%
|
1 530 938
-9%
|
1 641 304
+7%
|
1 700 030
+4%
|
1 792 685
+5%
|
1 874 589
+5%
|
2 723 454
+45%
|
2 709 846
0%
|
2 682 930
-1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
80 227
|
79 075
|
49 852
|
73 243
|
87 395
|
80 058
|
63 742
|
144 154
|
163 006
|
104 702
|
|
| Accrued Liabilities |
11 394
|
25 122
|
9 103
|
19 113
|
25 942
|
20 192
|
19 061
|
28 502
|
35 821
|
569
|
|
| Short-Term Debt |
28 071
|
12 868
|
1 664
|
1 279
|
1 279
|
1 297
|
2 007
|
1 342
|
1 351
|
713
|
|
| Current Portion of Long-Term Debt |
13 833
|
1 053
|
99 938
|
199 927
|
0
|
84 772
|
12 078
|
10 999
|
12 580
|
15 022
|
|
| Other Current Liabilities |
50 821
|
67 215
|
42 230
|
61 003
|
113 893
|
96 205
|
72 815
|
124 020
|
184 242
|
161 040
|
|
| Total Current Liabilities |
184 346
|
185 332
|
202 786
|
354 566
|
228 509
|
282 524
|
169 703
|
309 017
|
397 001
|
282 046
|
|
| Long-Term Debt |
388 018
|
303 187
|
199 787
|
79 812
|
79 891
|
2 866
|
4 846
|
10 110
|
7 900
|
6 507
|
|
| Deferred Income Tax |
39 997
|
2 026
|
0
|
0
|
2 706
|
4 813
|
20 874
|
103 113
|
0
|
0
|
|
| Minority Interest |
9 122
|
0
|
0
|
0
|
0
|
0
|
22 835
|
95 182
|
4 714
|
3 206
|
|
| Other Liabilities |
37 798
|
30 101
|
16 701
|
14 220
|
11 026
|
9 369
|
6 631
|
7 401
|
6 013
|
7 966
|
|
| Total Liabilities |
659 282
N/A
|
520 645
-21%
|
419 274
-19%
|
448 598
+7%
|
322 132
-28%
|
299 573
-7%
|
224 889
-25%
|
524 824
+133%
|
415 627
-21%
|
299 725
-28%
|
|
| Equity | |||||||||||
| Common Stock |
129 000
|
129 000
|
129 000
|
129 000
|
129 000
|
129 000
|
129 000
|
129 000
|
129 000
|
129 000
|
|
| Retained Earnings |
622 086
|
713 032
|
661 091
|
742 246
|
945 969
|
1 063 062
|
1 219 068
|
1 768 475
|
1 862 488
|
1 952 367
|
|
| Additional Paid In Capital |
330 944
|
330 944
|
330 944
|
330 944
|
330 944
|
330 944
|
330 944
|
330 944
|
330 944
|
330 944
|
|
| Unrealized Security Profit/Loss |
113 881
|
85
|
0
|
0
|
18 547
|
20 482
|
19 936
|
20 518
|
18 912
|
19 980
|
|
| Treasury Stock |
9 364
|
9 364
|
9 364
|
9 364
|
9 364
|
9 364
|
9 364
|
9 364
|
9 364
|
9 364
|
|
| Other Equity |
132
|
53
|
7
|
120
|
104
|
47
|
12
|
92
|
62
|
239
|
|
| Total Equity |
1 186 679
N/A
|
1 163 580
-2%
|
1 111 664
-4%
|
1 192 706
+7%
|
1 377 898
+16%
|
1 493 113
+8%
|
1 649 700
+10%
|
2 198 630
+33%
|
2 294 219
+4%
|
2 383 206
+4%
|
|
| Total Liabilities & Equity |
1 845 960
N/A
|
1 684 225
-9%
|
1 530 938
-9%
|
1 641 304
+7%
|
1 700 030
+4%
|
1 792 685
+5%
|
1 874 589
+5%
|
2 723 454
+45%
|
2 709 846
0%
|
2 682 930
-1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
25
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
